GlassScriptPhysician profile
Simona Scumpia
NPI 1689778946
$39,989.93
in general payments reported to CMS, 2019-2025
78 companies · $4,530 in 2025
The $4,530 reported for 2025 was more than what 87% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $3,910 · 2021: $6,364 · 2022: $4,679 · 2023: $4,217 · 2024: $4,207 · 2025: $4,530.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Education: $79.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,875.17 |
| Education | $79.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $5,968.05 | 2019-2025 | Synthroid |
| Novo Nordisk INC | $5,294.72 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $3,635.14 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Amgen INC. | $3,563.46 | 2019-2025 | Evenity, Repatha, Prolia |
| Astrazeneca Pharmaceuticals LP | $2,504.73 | 2019-2023 | Farxiga |
| Radius Health, INC. | $1,914.08 | 2019-2025 | Tymlos |
| Sanofi-Aventis U.S. LLC | $1,577.85 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,568.08 | 2019-2025 | Jardiance |
| Ibsa Pharma INC. | $1,226.07 | 2019-2025 | Tirosint, Licart, Tirosint |
| Bayer Healthcare Pharmaceuticals INC. | $1,103.52 | 2022-2025 | |
| Amarin Pharma, INC. | $1,024.27 | 2019-2023 | |
| Esperion Therapeutics, INC. | $1,017.58 | 2020-2025 | Nexletol, Nexlizet |
| Amneal Pharmaceuticals LLC | $891.45 | 2019-2025 | Unithroid |
| Janssen Pharmaceuticals, INC | $875.78 | 2019-2021 | |
| Tandem Diabetes Care, INC. | $803.66 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
Show all 78 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $619.93 | 2019-2025 | Korlym |
| Mannkind Corporation | $388.88 | 2020-2025 | Afrezza |
| Merck Sharp & Dohme LLC | $379.35 | 2019-2023 | Steglatro |
| Abbott Laboratories | $362.43 | 2019-2024 | Proclaim, Freestyle Libre 3, Protg |
| Clarus Therapeutics INC. | $283.95 | 2020-2021 | |
| Xeris Pharmaceuticals, INC. | $273.61 | 2021-2025 | Gvoke Hypopen, Recorlev |
| Dexcom, INC. | $272.84 | 2021-2025 | Dexcom G6 Transmitter |
| Medtronic, INC. | $259.85 | 2021-2025 | Minimed 780g, Medtronic Reusable Instruments |
| Horizon Therapeutics Plc | $238.06 | 2019-2023 | Tepezza |
| Astellas Pharma US INC | $221.09 | 2023-2025 | Veozah |
| Insulet Corporation | $211.78 | 2019-2025 | Omnipod |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $209.57 | 2020-2023 | Cycloset |
| Cequr Corporation | $202.45 | 2022-2025 | Cequr Simplicity |
| Zealand Pharma US, INC. | $193.57 | 2021-2022 | |
| Amryt Pharma Holdings LTD | $184.65 | 2022-2023 | Mycapssa |
| Echosens North America, INC. | $183.77 | 2025 | Fibroscan |
| Acerus Pharmaceuticals Corporation | $172.29 | 2020-2021 | |
| Recordati_rare_diseases_inc. | $164.52 | 2025 | Isturisa |
| Ipsen Biopharmaceuticals, INC | $123.29 | 2021-2023 | Somatuline Depot |
| Ascendis Pharma Endocrinology INC | $116.04 | 2023-2025 | Yorvipath |
| Madrigal Pharmaceuticals | $115.22 | 2024-2025 | Rezdiffra, Resmetirom |
| Novartis Pharmaceuticals Corporation | $107.94 | 2021-2023 | |
| Intuity Medical INC | $102.56 | 2022-2023 | Pogo Automatic Blood Glucose Monitoring System |
| Janssen Scientific Affairs, LLC | $98.30 | 2019 | |
| Jazz Pharmaceuticals INC. | $89.81 | 2021 | |
| Alexion Pharmaceuticals, INC. | $82.48 | 2020-2025 | Strensiq |
| Regeneron Healthcare Solutions, INC. | $81.28 | 2019-2021 | |
| Pfizer INC. | $72.76 | 2019-2023 | |
| Alvogen INC | $71.86 | 2023-2024 | Teriparatide |
| Inspire Medical Systems, INC. | $66.14 | 2023-2024 | Inspire |
| Sequel Med Tech, LLC | $60.75 | 2025 | Twiist |
| Currax Pharmaceuticals LLC | $59.43 | 2022-2025 | Contrave |
| Beta Bionics, INC. | $59.36 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Shire North American Group INC | $54.69 | 2019 | |
| Valeritas, INC. | $52.99 | 2019 | |
| Althera Pharmaceuticals LLC | $48.98 | 2021 | |
| Averitas Pharma INC. | $47.48 | 2024-2025 | Qutenza |
| Grt US Holding, INC. | $47.43 | 2021-2022 | |
| Chiesi USA, INC. | $47.05 | 2024 | Mycapssa |
| Neurocrine Biosciences, INC. | $44.34 | 2024 | |
| Itamar Medical INC | $42.57 | 2022-2023 | Watchpatone |
| Optos, INC. | $40.45 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $34.94 | 2019-2021 | |
| Rgh Enterprises LLC | $30.16 | 2025 | |
| Rhythm Pharmaceuticals, INC. | $29.63 | 2025 | Imcivree |
| Kowa Pharmaceuticals America, INC. | $27.97 | 2019 | |
| Nevro Corp. | $27.64 | 2024 | Senza |
| Ascensia Diabetes Care US INC. | $25.68 | 2025 | |
| Globus Medical, INC. | $25.15 | 2025 | Senza |
| Takeda Pharmaceuticals U.S.A., INC. | $23.25 | 2021 | |
| Intuitive Surgical, INC. | $21.89 | 2019 | |
| Kyowa Kirin, INC. | $21.47 | 2025 | |
| Glaxosmithkline, LLC. | $20.85 | 2025 | Shingrix |
| Eisai INC. | $20.71 | 2023 | |
| Antares Pharma, INC. | $20.40 | 2019 | |
| Aytu Biopharma, INC. | $19.68 | 2019 | |
| Tolmar, INC. | $19.49 | 2024 | |
| Shield Therapeutics INC | $18.56 | 2023 | Accrufer |
| Endo Pharmaceuticals INC. | $17.86 | 2020 | |
| Bigfoot Biomedical INC | $17.82 | 2022 | |
| Lifescan, INC. | $15.01 | 2019 | |
| Becton, Dickinson and Company | $14.92 | 2020 | |
| Alnylam Pharmaceuticals INC. | $12.62 | 2022 |
Drugs and devices associated with these payments
Ozempic $1,418Jardiance $1,201Mounjaro $977Rybelsus $958Wegovy $931Kerendia $803Tymlos $575Synthroid $535Evenity $498Zepbound $455Unithroid $428Repatha $388Tepezza $366Prolia $365Tzield $304T:Slim X2 Insulin Pump With Control-Iq $276Korlym $205Veozah $203Cequr Simplicity $189Fibroscan $184Tirosint $178Ilet Bionic Pancreas $178Isturisa $165Afrezza $156Proclaim $154Nexletol $151Dexcom G6 Transmitter $132Nexlizet $116Licart $112Rezdiffra $97.76Gvoke Hypopen $92.89Mycapssa $88.46Toujeo $87.09Minimed 780g $76.23Yorvipath $73.37Teriparatide $71.86Inspire $66.14Farxiga $65.91Twiist $60.75Senza $52.79Omnipod $50.47Freestyle Libre 3 $48.88Contrave $47.64Qutenza $47.48Vascepa $44.94Ubrelvy $42.73Pogo Automatic Blood Glucose Monitoring System $35.98Leqvio $32.90Medtronic Reusable Instruments $32.30Somavert $31.06Imcivree $29.63Ilet Insulin Infusion Kit Contact Detach $29.18Ilet Insulin Infusion Kit Inset $29.18Cycloset $28.57Somatuline Depot $26.70Soliqua 100/33 $25.29Watchpatone $24.83Flector $24.25Recorlev $21.84Crysvita $21.47Strensiq $21.30Shingrix $20.85Baqsimi $20.85Lyumjev $20.85Lenvima $20.71Jatenzo $19.49Saxenda $19.41Accrufer $18.56Resmetirom $17.46Steglatro $15.89Trulicity $14.06Humulin $11.03Protg $8.99
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simona Scumpia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.